Silo Pharma Stock Probability of Future OTC Stock Price Finishing Over 5.61
| SILO Stock | USD 0.86 0.05 5.49% |
Silo |
Silo Pharma Target Price Odds to finish over 5.61
The tendency of Silo OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 5.61 or more in 90 days |
| 0.86 | 90 days | 5.61 | close to zero percent |
Based on a normal probability distribution, the odds of Silo Pharma to move over $ 5.61 or more in 90 days from now is close to zero percent (This Silo Pharma probability density function shows the probability of Silo OTC Stock to fall within a particular range of prices over 90 days) . Probability of Silo Pharma price to stay between its current price of $ 0.86 and $ 5.61 at the end of the 90-day period is close to 99 .
Given the investment horizon of 90 days Silo Pharma has a beta of -0.13. This usually implies as returns on the benchmark increase, returns on holding Silo Pharma are expected to decrease at a much lower rate. During a bear market, however, Silo Pharma is likely to outperform the market. Additionally Silo Pharma has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Silo Pharma Price Density |
| Price |
Predictive Modules for Silo Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Silo Pharma. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Silo Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Silo Pharma is not an exception. The market had few large corrections towards the Silo Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Silo Pharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Silo Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.6 | |
β | Beta against Dow Jones | -0.13 | |
σ | Overall volatility | 0.11 | |
Ir | Information ratio | -0.15 |
Silo Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Silo Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Silo Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Silo Pharma generated a negative expected return over the last 90 days | |
| Silo Pharma has some characteristics of a very speculative penny stock | |
| Silo Pharma has high historical volatility and very poor performance | |
| Silo Pharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 72.1 K. Net Loss for the year was (3.63 M) with profit before overhead, payroll, taxes, and interest of 66.26 K. | |
| Silo Pharma currently holds about 8.85 M in cash with (3.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Silo Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Silo OTC Stock often depends not only on the future outlook of the current and potential Silo Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Silo Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3.1 M | |
| Cash And Short Term Investments | 7.7 M |
Silo Pharma Technical Analysis
Silo Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Silo OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Silo Pharma. In general, you should focus on analyzing Silo OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Silo Pharma Predictive Forecast Models
Silo Pharma's time-series forecasting models is one of many Silo Pharma's otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Silo Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Silo Pharma
Checking the ongoing alerts about Silo Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Silo Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Silo Pharma generated a negative expected return over the last 90 days | |
| Silo Pharma has some characteristics of a very speculative penny stock | |
| Silo Pharma has high historical volatility and very poor performance | |
| Silo Pharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 72.1 K. Net Loss for the year was (3.63 M) with profit before overhead, payroll, taxes, and interest of 66.26 K. | |
| Silo Pharma currently holds about 8.85 M in cash with (3.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Other Information on Investing in Silo OTC Stock
Silo Pharma financial ratios help investors to determine whether Silo OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Silo with respect to the benefits of owning Silo Pharma security.